期刊文献+

血管紧张素转换酶基因多态性与血管紧张素转换酶抑制剂疗效的相关性 被引量:10

Polymorphism of the Angiotensin Converting Enzyme Gene and The Response to Angiotensin Converting Enzyme Inhibition in Hypertensive Patients
下载PDF
导出
摘要 目的 研究原发性高血压 (EH)患者的血管紧张素转换酶 (ACE)基因多态性与血管紧张素转换酶抑制剂 (ACEI)疗效的相关性。方法  ( 1)用ACEI对 5 17例EH患者进行为期 6周的降压治疗 ,所用药物为咪达普利或苯那普利。 ( 2 )用聚合酶链反应 (PCR)方法检测患者的ACE基因多态性 ,ACE基因有 3种表现型 :II型、DD型和DI型。 ( 3 )治疗前后及治疗过程中对患者的收缩压、舒张压和心率进行监测。结果  ( 1)在总共 5 17例患者中 ,ACE基因型为DD者有 13 2人( 2 5 5 % ) ,II者有 13 0人 ( 2 5 2 % ) ,ID者有 2 5 5人 ( 4 9 3 % )。 ( 2 )不同基因型组间的性别、年龄、体重指数及心率等的差异无统计学意义。 ( 3 )在这三组患者中 ,治疗前后收缩压的降幅分别为 ( -14 5± 12 7)mmHg ,( -14 3± 13 1)mmHgand( -14 0± 12 2 )mmHg (P =0 94) ,舒张压的降幅分别为 ( -8 7± 7 4)mmHg ,( -8 7± 7 7)mmHgand ( -8 5± 6 7)mmHg (P =0 96)。结论 本研究没有发现EH患者的ACE基因多态性与ACEI的降压疗效相关 ,据此 。 Objective To investigate the relationship between polymorphism of the angiotensin converting enzyme (ACE) gene and the blood pressure response to ACE inhibition in a hypertensive cohort. Methods Imidapril or Benazepril was administered for 6 weeks to 517 essential hypertensives. ACE gene polymorphism was examined by the polymerase chain reaction (PCR) method and the patients was classified as DD, ID and II genotype. The change in systolic and diastolic blood pressure was analysed for association with genotypes of ACE gene. Results The frequency of DD genotype was 25.5%(132 patients), the ID genotype 49.3%(255 patients) and the II genotyp 25.2%(130 patients). The systolic blood pressure reduction in the patients with DD genotype, II genotype and ID genotype were (-14.5±12.7) mmHg, (-14.3±13.1) mmHg and (-14.0±12.2) mmHg, respectively (P=0.94). The diastolic blood pressure reduction in the patients with DD genotype, II genotype and ID genotype were (-8.7±7.4) mmHg, (-8.7±7.7) mmHg and (-8.5±6.7) mmHg, respectively (P=0.96). Conclution No significant association between the ACE gene polymorphism and the response of BP reduction by ACEI was found. These results suggest that ACE genotypes do not associate to the blood pressure-lowing response to antihypertensive treatment with ACE inhibition.
出处 《高血压杂志》 CSCD 2004年第3期207-210,共4页 Chinese Journal of Hypertension
关键词 原发性高血压 血管紧张素转换酶 血管紧张素转换酶抑制剂 基因型 多态性 essential hypertension angiotensin converting enzyme angiotensin converting enzyme inhibition genotype polymorphism
  • 相关文献

参考文献12

  • 1Daly A,Brockmoller J,Broly F,et al.Nomenclature for human CYP2D6 alleles[J ].Pharmacogenetics,1996,6:193-201.
  • 2Tiret L,rigat B,Visviks S,et al.Evidence from combined segregation and linkage analysis that a variant of the ACE gene controls plasma levels[J].Am J Hum Genet,1992,1:197-205.
  • 3Nakano Y,Oshima T,Watanabe M,et al.Angiotensin 1 -converting enzyme gene polymorphism and acute response to captopril in essential hypertension[ J ].Am J Hypertens,1997,10:1064-1068.
  • 4UedaS,Meredith PA,Morton JJ,et al.ACE(I/D)genotypeasapredictor of the magnitude and duration of the response an ACE inhibitor drug (enalaprilat) in humans[J].Criculation,1998,98:2148-2153.
  • 5George A S,Thomas K M,Panagiota G K,et al.Predicting response to chronic antihypertensive treatment with fosinopril: The role of angiotensin-converting enzyme gene polymorphism [J ].Cardiovascular Drugs and therapy,2000,14: 427-432.
  • 6Hingorani AD,Jia H,Stevens PA,et al.Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition[J ].J Hypertens,1995,13:1602-1609.
  • 7Dudley C,Kesvney B,Casadei B,et al.Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of the renin-angiotensin system genes[ J ].J Hypertens,1996,14: 259-262.
  • 8Lisa Kurland,Hakan Melhus,Julia Karlsson,et al.Angiotensin converting enzyme gene polymorphiem predicts blood pressure response to angiotensin Ⅱ receptor type 1 antagonist treatment in hypertensive patients[ J ].J Hypertens,2001,19: 1783-1787.
  • 9Miller JA,Thai K,Scholey JW.Angiotensin Ⅱ type 1 receptor gene polymorphism predicts response to losartan and angiotensin Ⅱ [J].Kidney Int,1999,56 : 2173-2180.
  • 10Mondorf U,Russ A,Wiesemann A,et al.Contribution of ACE gene polymorphism and angiotensinogen gene polymorphism to blood pressure reduction in essential hypertension[J ].Am J Hypertens,1998,11:174-183.

同被引文献91

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部